BLOOM NUTRITION SWOT ANALYSIS TEMPLATE RESEARCH B_61 with an expected annual growth

with an expected annual growth rate of 30%

Top segment share - estimated 20%+ in 2025

Epigenetic reprogramming could restore youthful cellular health

Technical limitations and scalability issues can hinder market adoption

Funds potential commercialization of atacicept

BLOOM NUTRITION SWOT ANALYSIS TEMPLATE RESEARCH B_61 with an expected annual growthElevate Your Analysis with the Complete SWOT Report Bloom Nutrition shows promising product market fit with clean label offerings and direct to consumer traction, but faces supply chain pressure and intensifying competition in functional foods. Purchase the full SWOT analysis to access a research backed, editable report and Excel matrix that reveal strategic levers, financial context, and prioritized actions for investors and operators. Strengths Over